expand_moreexpand_less
Aeon
Al Jazeera
América Economía
Blitz
Buenos Aires Herald
Deutsche Welle
Dnevnik
E-International
Haaretz
Il Manifesto Global
Japan Today
Khaama PressMiddle East Monitor
New Eastern OutlookNikkei Asian ReviewOped Column
Pravda.sk
Project Syndicate
Psychology TodayRT.comSME.sk
South China Morning PostThe Asahi ShimbunThe DiplomatThe Japan NewsThe Japan Times
The Korea TimesThe Times of IsraelThe Times of Israel (Blogs)Večer
العين الإخبارية 
Toi StaffEmanuel FabianJacob MagidAgenciesLazar BermanJeremy SharonCanaan LidorGianluca PacchianiAmérica EconomíaThe Japan News EditorialReutersRon KampeasShahidul AlamLuke TressAndrew Lapin
Belen FernandezBen Knight
Gideon LevyZvi Bar&x27ElEhud OlmertAaron JosefczykDiana BletterAmy SpiroSandy TolanThe Asahi ShimbunSam SokolUri MisgavNik MartinCathryn J. PrinceWafa AludainiDavid Horovitz
Nikkei EditorialHaroon JanjuaJessica SteinbergHanin Majadli
Kenneth Cohen
Bernd Riegert
Patrick Gathara
Srecko HorvatRashid SumailaRobert BridgeMarko CrnkovičBen Sales
Ivan LorenčičSalah Uddin Shoaib ChoudhuryCharlie SummersRaviv DruckerJennifer HolleisGavriel FiskeAnshel Pfeffer
|
|
Madison MullerFortune |
The new Alzheimer's drug will cost $32,000 for the first year of treatment.
Hims said it’s offering a treatment with the same active ingredient as Wegovy for $199 a month.
Sanders wants to personally discuss the weight-loss drug's roughly $1,000-per-month price with Novo Nordisk CEO Lars Fruergaard Jørgensen.
A joint study between Yale University, King’s College Hospital in London and Doctors Without Borders found a single shot of the blockbuster drug...
Sweetgreen was the only restaurant that saw a boost in visits from those taking the shots, according to a new survey.
Patients given a monthly injection of the drug, dubbed MariTide, lost up to 14.5% of their body weight in just 12 weeks, according to a small,...
login
who are we?
contact us
qosheapp
